Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/41895
Title: Effects of visceral adipose tissue reduction on CVD risk factors independent of weight loss: The Look AHEAD study
Authors: Anawin Sanguankeo
Mariana Lazo
Sikarin Upala
Frederick L. Brancati
Susanne Bonekamp
Henry J. Pownall
Ashok Balasubramanyam
Jeanne M. Clark
Mahidol University
Columbia University, College of Physicians and Surgeons
Johns Hopkins Bloomberg School of Public Health
Johns Hopkins University
The Welch Center for Prevention, Epidemiology, Prevention and Clinical Research
The Johns Hopkins School of Medicine
Weill Cornell Medical College
Baylor College of Medicine
Keywords: Biochemistry, Genetics and Molecular Biology
Issue Date: 3-Apr-2017
Citation: Endocrine Research. Vol.42, No.2 (2017), 86-95
Abstract: © 2017 Taylor & Francis. Objectives: To determine if the reduction of visceral adipose tissue (VAT) volume by lifestyle intervention improved risk factors for cardiovascular disease (CVD) independent of weight loss amount. Design: Ancillary study of randomized-controlled trial. Setting: Data analysis using multivariable regression models. Participants: Participants of the Look AHEAD (Action for HEAlth in Diabetes) Fatty Liver Ancillary Study. Main outcome measures: Correlations between changes in VAT and in CVD risk factors, while adjusting for weight loss and treatment (intensive lifestyle intervention [ILI] vs. diabetes support and education [DSE]). Results: Of 100 participants analyzed, 52% were women, and 36% were black, with a mean age of 61.1 years. In the DSE group, mean weight and VAT changed by 0.1 % (p=0.90) and 4.3% (p=0.39), respectively. In the ILI group, mean weight and VAT decreased by 8.0% (p<0.001) and 7.7% (p=0.01), respectively. Across both groups, mean weight decreased by 3.6% (p<0.001), and mean VAT decreased by 1.2% (p=0.22); the decrease in VAT was correlated with the increase in HDL-cholesterol (HDL-C; R=−0.37; p=0.03). There were no correlations between changes in VAT and blood pressure, triglycerides, LDL-C, glucose, or HbA1c. After adjusting for age, race, gender, baseline metabolic values, fitness, and treatment group, changes in HDL-C were not associated with changes in VAT, while weight changes were independently associated with decrease in glucose, HbA1c, and increase in HDL-C. Conclusions: VAT reduction was not correlated with improvements of CVD risk factors in a sample of overweight and obese adults with type 2 diabetes after adjusting for weight loss.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84976388643&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/41895
ISSN: 15324206
07435800
Appears in Collections:Scopus 2016-2017

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.